Osaühing A.A.T.Meele

Active Registry code 11497203 OÜ Tartu linn Registered 21 May 2008
Compare

Osaühing A.A.T.Meele is a OÜ based in Tartu linn, registry code 11497203, status: active. Main activity: Medical specialists activities. According to EMTA, turnover for Q3 2026 was €4 950 with employees.

Turnover
4 950 €
↓ 77.5% vs Q2 2026
State taxes
788 €
↓ 83.1% vs Q2 2026
Labour taxes
0 €
Employees
—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Human health activities · EMTAK 86

  • Turnover · Q3 2026 4 950 €
    industry median 9 428 € · companies in the industry: 351
  • Revenue · 2025 52 449 €
    industry median 20 811 € · companies in the industry: 3 373
  • Net profit margin · 2025 52.4 %
    industry median 8.3 % · companies in the industry: 2 759

Taxes and turnover

Q4 2025 – Q3 2026
Turnover, € Q3 2026: 4 950 € · −77.5% vs Q2 2026 · industry median 9 428 € · above 37% of the industry
05 00010 00015 00020 00025 000Q4 2025 Company: 8 690 € Industry median: 11 366 €Q4·25Q1 2026 Company: 13 430 € Industry median: 10 630 €Q1·26Q2 2026 Company: 21 990 € Industry median: 11 295 €Q2·26Q3 2026 Company: 4 950 € Industry median: 9 428 €Q3·2605 00010 00015 00020 00025 000Q4 2025 Company: 8 690 € Industry median: 11 366 €Q1 2026 Company: 13 430 € Industry median: 10 630 €Q1·26Q2 2026 Company: 21 990 € Industry median: 11 295 €Q3 2026 Company: 4 950 € Industry median: 9 428 €Q3·26
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

State taxes, € Q3 2026: 788 € · −83.1% vs Q2 2026
01 0002 0003 0004 0005 000Q4 2025 Company: 2 078 €Q4·25Q1 2026 Company: 3 025 €Q1·26Q2 2026 Company: 4 664 €Q2·26Q3 2026 Company: 788 €Q3·2601 0002 0003 0004 0005 000Q4 2025 Company: 2 078 €Q1 2026 Company: 3 025 €Q1·26Q2 2026 Company: 4 664 €Q3 2026 Company: 788 €Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 4 950 788 — —
Q2 2026 21 990 4 664 — —
Q1 2026 13 430 3 025 — —
Q4 2025 8 690 2 078 — —

Financials by year

2016 – 2025
Revenue, € 2025: 52 449 € · +33.3% vs 2024 · industry median 20 811 € · above 65% of the industry
020 00040 00060 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 25 458 € Industry median: 25 166 €20192020 Company: 19 387 € Industry median: 20 220 €20202021 Company: 22 310 € Industry median: 20 121 €20212022 Company: 25 108 € Industry median: 20 030 €20222023 Company: 16 776 € Industry median: 19 469 €20232024 Company: 39 354 € Industry median: 20 000 €20242025 Company: 52 449 € Industry median: 20 811 €2025020 00040 00060 0002018 Company: — Industry median: —2019 Company: 25 458 € Industry median: 25 166 €20192020 Company: 19 387 € Industry median: 20 220 €2021 Company: 22 310 € Industry median: 20 121 €20212022 Company: 25 108 € Industry median: 20 030 €2023 Company: 16 776 € Industry median: 19 469 €20232024 Company: 39 354 € Industry median: 20 000 €2025 Company: 52 449 € Industry median: 20 811 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 27 458 € · −15.0% vs 2024 · industry median 1 071 € · above 80% of the industry
010 00020 00030 00040 0002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 19 441 € Industry median: 2 596 €20192020 Company: 8 897 € Industry median: 2 208 €20202021 Company: 13 213 € Industry median: 1 834 €20212022 Company: 10 140 € Industry median: 1 525 €20222023 Company: 7 872 € Industry median: 1 745 €20232024 Company: 32 290 € Industry median: 1 621 €20242025 Company: 27 458 € Industry median: 1 071 €2025010 00020 00030 00040 0002018 Company: — Industry median: —2019 Company: 19 441 € Industry median: 2 596 €20192020 Company: 8 897 € Industry median: 2 208 €2021 Company: 13 213 € Industry median: 1 834 €20212022 Company: 10 140 € Industry median: 1 525 €2023 Company: 7 872 € Industry median: 1 745 €20232024 Company: 32 290 € Industry median: 1 621 €2025 Company: 27 458 € Industry median: 1 071 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 52.4 % · −29.7 pp vs the year before · industry median 8.3 % · above 89% of the industry
0204060801002016 Company: — Industry median: —20162017 Company: — Industry median: —20172018 Company: — Industry median: —20182019 Company: 76.4 % Industry median: 10.3 %20192020 Company: 45.9 % Industry median: 12.4 %20202021 Company: 59.2 % Industry median: 13.0 %20212022 Company: 40.4 % Industry median: 11.3 %20222023 Company: 46.9 % Industry median: 11.4 %20232024 Company: 82.1 % Industry median: 10.7 %20242025 Company: 52.4 % Industry median: 8.3 %20250204060801002018 Company: — Industry median: —2019 Company: 76.4 % Industry median: 10.3 %20192020 Company: 45.9 % Industry median: 12.4 %2021 Company: 59.2 % Industry median: 13.0 %20212022 Company: 40.4 % Industry median: 11.3 %2023 Company: 46.9 % Industry median: 11.4 %20232024 Company: 82.1 % Industry median: 10.7 %2025 Company: 52.4 % Industry median: 8.3 %2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 122 114 € · +31.3% vs 2024
02550751001252016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 33 537 €20192020 Company: 27 751 €20202021 Company: 41 565 €20212022 Company: 52 799 €20222023 Company: 59 888 €20232024 Company: 93 012 €20242025 Company: 122 114 €202502550751001252018 Company: —2019 Company: 33 537 €20192020 Company: 27 751 €2021 Company: 41 565 €20212022 Company: 52 799 €2023 Company: 59 888 €20232024 Company: 93 012 €2025 Company: 122 114 €2025
Equity, € thousand 2025: 116 616 € · +30.8% vs 2024
02550751001252016 Company: —20162017 Company: —20172018 Company: —20182019 Company: 33 140 €20192020 Company: 25 644 €20202021 Company: 38 857 €20212022 Company: 48 997 €20222023 Company: 56 868 €20232024 Company: 89 158 €20242025 Company: 116 616 €202502550751001252018 Company: —2019 Company: 33 140 €20192020 Company: 25 644 €2021 Company: 38 857 €20212022 Company: 48 997 €2023 Company: 56 868 €20232024 Company: 89 158 €2025 Company: 116 616 €2025
Employees 2025: 0 · industry median 2 · above 2% of the industry
01232016 Company: 0 Industry median: —20162017 Company: 0 Industry median: —20172018 Company: 0 Industry median: 320182019 Company: 0 Industry median: 320192020 Company: 0 Industry median: 320202021 Company: 0 Industry median: 2.520212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 220232024 Company: 0 Industry median: 220242025 Company: 0 Industry median: 2202501232018 Company: 0 Industry median: 32019 Company: 0 Industry median: 320192020 Company: 0 Industry median: 32021 Company: 0 Industry median: 2.520212022 Company: 0 Industry median: 22023 Company: 0 Industry median: 220232024 Company: 0 Industry median: 22025 Company: 0 Industry median: 22025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 52 449 27 458 0 122 114 116 616 0
2024 39 354 32 290 0 93 012 89 158 0
2023 16 776 7 872 0 59 888 56 868 0
2022 25 108 10 140 0 52 799 48 997 0
2021 22 310 13 213 0 41 565 38 857 0
2020 19 387 8 897 0 27 751 25 644 0
2019 25 458 19 441 0 33 537 33 140 0
2018 — — — — — 0
2017 — — — — — 0
2016 — — — — — 0
2015 — — — — — 0
2014 — — — — — 0
2013 — — — — — 0
2012 — — — — — 0
2011 — — — — — 0
2010 — — — — — 1
2009 — — — — — 0
2008 — — — — — 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
52.4 %
Net profit / revenue
Return on equity (ROE)
23.5 %
Net profit / equity
Return on assets (ROA)
22.5 %
Net profit / assets
Equity ratio
95.5 %
Equity / assets
Debt ratio
4.5 %
Liabilities / assets
Current ratio
10.47
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 18 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 30 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 1 Jun 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 31 May 2023 Company’s own e-Äriregister
2021 1 Jan 2021 – 31 Dec 2021 17 Jun 2022 Company’s own e-Äriregister
2020 1 Jan 2020 – 31 Dec 2020 18 May 2021 Company’s own e-Äriregister
2019 1 Jan 2019 – 31 Dec 2019 30 Jun 2020 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 86221Medical specialists activities Main
Rulings
Number, date Title Deadline State Document
Ä 20041468 / 9
2 Sep 2023
Amendment entry In force
2 Sep 2023
PDF
Ä 20041468 / 8
30 Oct 2020
Amendment entry In force
30 Oct 2020
PDF
Ä 20041468 / M4
27 Oct 2020
Ruling to eliminate deficiencies 3 Nov 2020 Deficiencies eliminated
28 Oct 2020
PDF
Ä 20041468 / M3
24 Oct 2018
Ruling to eliminate deficiencies 5 Nov 2018 Deficiencies eliminated
29 Oct 2018
PDF
Ä 20041468 / 7
29 Jun 2018
Amendment entry In force
29 Jun 2018
PDF
Ä 20041468 / 6
21 Feb 2018
Amendment entry In force
21 Feb 2018
PDF
Ä 20041468 / 5
18 Jan 2018
Amendment entry In force
18 Jan 2018
PDF
Ä 20041468 / 4
26 May 2017
Amendment entry In force
26 May 2017
PDF
Ä 20041468 / 3
19 Aug 2016
Entry refused: deficiencies not eliminated In force
6 Sep 2016
PDF
Ä 20041468 / M2
22 Jun 2016
Ruling to eliminate deficiencies 22 Jul 2016 In force
22 Jun 2016
PDF
Ä 20041468 / 2
27 Feb 2012
Amendment entry In force
27 Feb 2012
PDF
Ä 20041468 / M1
23 Dec 2011
Ruling to eliminate deficiencies In force
23 Dec 2011
PDF
Ä 41468
21 May 2008
First entry In force
21 May 2008
PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data